2. Neuronal Signaling Protein Tyrosine Kinase/RTK
  3. Trk Receptor FLT3 VEGFR RET
  4. TRK II-IN-1

TRK II-IN-1 is a potent type II TRK inhibitor, with IC50s of 3.3, 6.4, 4.3 and 9.4 nM, for TRKA/B/C and TRKAG667C, respectively. TRK II-IN-1 also inhibits FLT3, RET, and VEGFR2 with IC50s of 1.3, 9.9, and 71.1 nM, respectively. TRK II-IN-1 can be used for the research of TRK driven cancers.

For research use only. We do not sell to patients.

TRK II-IN-1 Chemical Structure

TRK II-IN-1 Chemical Structure

CAS No. : 2904690-41-9

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

TRK II-IN-1 Related Antibodies

Top Publications Citing Use of Products

View All Trk Receptor Isoform Specific Products:

View All Isoforms
TrkA TrkB TrkC Trk

View All VEGFR Isoform Specific Products:

View All Isoforms
VEGFR1/Flt-1 VEGFR2/KDR/Flk-1 VEGFR3/Flt-4

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

TRK II-IN-1 is a potent type II TRK inhibitor, with IC50s of 3.3, 6.4, 4.3 and 9.4 nM, for TRKA/B/C and TRKAG667C, respectively. TRK II-IN-1 also inhibits FLT3, RET, and VEGFR2 with IC50s of 1.3, 9.9, and 71.1 nM, respectively. TRK II-IN-1 can be used for the research of TRK driven cancers[1].

IC50 & Target[1]

TrkA

3.3 nM (IC50)

TrkB

6.4 nM (IC50)

TrkC

4.3 nM (IC50)

TRKAG667C

9.4 nM (IC50)

FLT3

1.3 nM (IC50)

RET

9.9 nM (IC50)

VEGFR2

71.1 nM (IC50)

In Vitro

TRK II-IN-1 (compound 12d) (1 μM) demonstrates over 90% of kinase inhibition towards VEGFR2, RET, FLT3 and nearly 70% inhibition against Kit, CSF1R, DDR1 and DDR2[1].
TRK II-IN-1 (72 h) inhibits Ba/F3-CD74-TRKA, Ba/F3-ETV6-TRKB and Ba/F3-ETV6-TRKC cells, with IC50s of 26.1, 44.7 and 15.7 nM, respectively[1].
TRK II-IN-1 (72 h) suppresses proliferation of a panel of Ba/F3 cells stably transformed with wild type, xDFG as well as solvent-front (SF) mutant TRK fusion proteins, with IC50s ranging from 2.6 to 143.3 nM[1].
TRK II-IN-1 (0.4-500 nM; 48 h) induces apoptosis of Ba/F3-CD74-TRKA and Ba/F3-CD74-TRKAG667C cells[1].
TRK II-IN-1 (0.4-500 nM; 24 h) arrests cell cycle progression in the G0/G1 phase in Ba/F3-CD74-TRKA and Ba/F3-CD74-TRKAG667C cells[1].
TRK II-IN-1 (0.8-500 nM; 6 h) suppresses the phosphorylation of TRKA, TRKAG667C kinases, and their downstream AKT, ERK and PLCγ1 in a dose-dependent manner[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

TRK II-IN-1 Related Antibodies

Apoptosis Analysis[1]

Cell Line: Ba/ F3 stable cell lines expressing wild type and G667C mutant fusions
Concentration: 0.4, 2, 10, 50 nM for Ba/F3-CD74-TRKA cells; 4, 20, 100, 500 nM for Ba/F3-CD74-TRKAG667C cells
Incubation Time: 48 hours
Result: Notable apoptotic cells (18.74% in 100 nM and 35.65% in 500 nM) were observed in Ba/F3-CD74-TRKA cells.
Induced Ba/F3-CD74-TRKAG667C cell apoptosis with 11.22% and 56.25% at the concentration of 10 nM and 50 nM, respectively.

Cell Cycle Analysis[1]

Cell Line: Ba/ F3 stable cell lines expressing wild type and G667C mutant fusions
Concentration: 0.4, 2, 10, 50 nM for Ba/F3-CD74-TRKA cells; 4, 20, 100, 500 nM for Ba/F3-CD74-TRKAG667C cells
Incubation Time: 24 hours
Result: Arrested cell cycle progression in the G0/G1 phase.

Western Blot Analysis[1]

Cell Line: Ba/ F3 stable cell lines expressing wild type and G667C mutant fusions
Concentration: 0.8, 4, 20, 100, 500 nM
Incubation Time: 6 hours
Result: Inhibited the activation of TRKA and downstream signaling.
Molecular Weight

564.60

Formula

C29H31F3N8O
CAS No.
SMILES

CN1CCN(CC1)CC2=CC=C(C=C2C(F)(F)F)NC([C@@H]3CCN(C3)C4=NN5C(C6=NC=CC=C6)=CN=C5C=C4)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

TRK II-IN-1 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

TRK II-IN-12904690-41-9Trk ReceptorFLT3VEGFRRETTropomyosin related kinase receptor Cluster of differentiation antigen 135CD135Fms like tyrosine kinase 3Vascular endothelial growth factor receptorTRKAG667Csolvent-frontxDFGInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
TRK II-IN-1
Cat. No.:
HY-151945
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.